Cincinnati Business Courier: Flash therapy for cancer
Clinical trial led by a UC faculty member looks at cancer therapy delivered in less than a second
UC researchers treated their first study patient this week using a new cancer therapy that takes less than one second.
The trial, being hosted at the Cincinnati Children's Hospital Medical Center/UC Health Proton Therapy Center, is looking at what is known as "flash" therapy, a new mode of radiation that can be delivered to a patient in as little as a single session that lasts less than one second. It is up to 100 times faster than traditional radiation therapy, which delivers the same dose over minutes.
The study patient, the first in the world to participate in the clinical trial, was treated this week at the center. Up to 10 patients, whose metastatic cancer has spread to their bones, will participate in the research clinical trial.
John Breneman, MD, a professor emeritus at UC who is medical director of the center, a UC Health radiation oncologist and principal investigator on the study, says the patient's treatment went very well.
“The prior three years of preparation by the researchers, engineers, clinical and physics teams culminated in a treatment that was completed in literally a blink of the eye, and the patient was discharged,” he says.
Read the full Cincinnati Business Courier story. This publication may require a login.
Read coverage at Healthcare Business News.
Read the Cincinnati Children's media release.
Featured photo of the Cincinnati Children's/UC Health Proton Therapy Center taken in 2019 by Colleen Kelley/UC Creative + Brand.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.